SIMPONI Trademark

Trademark Overview

On Wednesday, October 5, 2005, a trademark application was filed for SIMPONI with the United States Patent and Trademark Office. The USPTO has given the SIMPONI trademark a serial number of 76647994. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 5, 2010. This trademark is owned by JOHNSON & JOHNSON. The SIMPONI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for treatment of autoimmune diseases
simponi

General Information

Serial Number76647994
Word MarkSIMPONI
Filing DateWednesday, October 5, 2005
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 5, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2006

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for treatment of autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 7, 2005
Primary Code005
First Use Anywhere DateTuesday, April 28, 2009
First Use In Commerce DateTuesday, April 28, 2009

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Friday, November 5, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 5, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 5, 2010NON-FINAL ACTION MAILED
Friday, April 2, 2010SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 9, 2010STATEMENT OF USE PROCESSING COMPLETE
Saturday, March 6, 2010USE AMENDMENT FILED
Monday, March 8, 2010TEAS STATEMENT OF USE RECEIVED
Thursday, September 10, 2009EXTENSION 5 GRANTED
Friday, September 4, 2009EXTENSION 5 FILED
Friday, September 4, 2009TEAS EXTENSION RECEIVED
Friday, May 15, 2009ASSIGNED TO EXAMINER
Wednesday, March 4, 2009EXTENSION 4 GRANTED
Monday, March 2, 2009EXTENSION 4 FILED
Monday, March 2, 2009TEAS EXTENSION RECEIVED
Wednesday, September 3, 2008EXTENSION 3 GRANTED
Friday, August 22, 2008EXTENSION 3 FILED
Wednesday, September 3, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 22, 2008TEAS EXTENSION RECEIVED
Thursday, March 6, 2008EXTENSION 2 GRANTED
Thursday, March 6, 2008EXTENSION 2 FILED
Thursday, March 6, 2008TEAS EXTENSION RECEIVED
Tuesday, September 4, 2007EXTENSION 1 GRANTED
Tuesday, September 4, 2007EXTENSION 1 FILED
Tuesday, September 4, 2007TEAS EXTENSION RECEIVED
Tuesday, March 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2006NOTICE OF PUBLICATION
Tuesday, October 17, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 13, 2006ASSIGNED TO LIE
Wednesday, October 11, 2006EXAMINERS AMENDMENT MAILED
Wednesday, October 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, October 11, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 6, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 6, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 17, 2006PRIORITY ACTION MAILED
Monday, April 17, 2006PRIORITY ACTION WRITTEN
Monday, April 10, 2006ASSIGNED TO EXAMINER
Friday, October 7, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

simponi autoimmune diseases treatment preparations pharmaceutical human